Novotech Clinical Research (Poland)sp. z o.o.
Other research and experimental development on natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2009-06-15
Share capital
5,000.00 PLN
Registered address
ul. Marszałkowska 142, 00-061 Warszawa, Poland
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2024, 36 days late).
- 202501/07/2026
- 202420/08/2025
- 202327/05/2024
- 202229/03/2023
- 202125/05/2022
- 202021/06/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 5.14mMedianUSD 73.26kAverageUSD 3.23m
Net profit
This companyUSD 152.52kMedianUSD 68.58AverageUSD 82.17k
Operating costs
This companyUSD 4.94mMedianUSD 75.78kAverageUSD 3.04m
Assets
This companyUSD 1.45mMedianUSD 119.88kAverageUSD 3.90m
Industry
- Management consultancy activities (70.2)
- Research and experimental development in natural sciences and engineering (72.1)
Authorized Representatives
Scott Andrew Davis – Management Board Member
Krzysztof Stanisław Lipiński – Management Board Member
Manner of representation
1. The company is represented by each member of the management board independently.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2009-08-18.
16 1240 1040 1111 0010 9962 1503
68 1240 1040 1787 0011 0693 4420
77 1240 1040 1978 0010 9962 1675
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Sieć Badawcza Łukasiewicz - Instytut Przemysłu OrganicznegoResearch institute | $10,664,333.00 | ipo.lukasiewicz.gov.pl | ||
| Sieć Badawcza Łukasiewicz - Przemysłowy Instytut MotoryzacjiResearch institute | $9,941,910.15 | pimot.lukasiewicz.gov.pl | ||
| MedicalgorithmicsS.A. | $6,960,823.71 | medicalgorithmics.com | ||
| Sidlysp. z o.o. | $4,977,649.42 | sidly.eu | ||
| Wojskowy Instytut Chemii i RadiometriiResearch institute | $4,801,935.31 | wichir.waw.pl | ||
| Scope FluidicsS.A. | $4,660,220.99 | scopefluidics.com | ||
| Instytut Fizyki Plazmy i Laserowej Mikrosyntezy Im. Sylwestra KaliskiegoResearch institute | $4,428,142.48 | ifpilm.pl | ||
| Under Antsp. z o.o. + limited partnership | $2,752,130.50 | underant.com | ||
| Centrum Badań i Rozwoju Technologii dla PrzemysłuS.A. | $2,559,521.35 | cbrtp.pl | ||
| Wealtharcsp. z o.o. | $2,551,576.83 | wealtharc.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-08-26 | Name change (Easthorn Clinical Services In Cee → Novotech Clinical Research (poland)) | |
| 2022-09-05 | Address change (Pańska 73/804, 00-834, Warszawa → Ul. Marszałkowska 142, 00-061, Warszawa) | |
| 2022-09-05 | PKD change (Added: 72.19.Z) | |
| 2012-09-11 | Address change (Stawki 2/16p,iv1/4p, 00-193, Warszawa → Pańska 73/804, 00-834, Warszawa) | |
| 2010-10-11 | Address change (Bonifraterska 17, 00-203, Warszawa → Stawki 2/16p,iv1/4p, 00-193, Warszawa) |
FAQ
The main business activity of Novotech Clinical Research (Poland) focuses on other research and experimental development on natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on June 15, 2009.
The headquarters is located at: ul. Marszałkowska 142, 00-061 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 5,144,973, representing an increase of 7.7% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of USD 152,525, meaning the company increased its profit by 10.8%.
The largest operating cost category falls under employee remuneration. This category amounted to USD 3,728,016 in 2025, representing 75% of all operating expenses.
Last updated: 2026-10-02